Menu

Update

Register: Virtual ENACT Day 2021

Join PHI’s CA4Health and partners for ENACT Day, an annual advocacy event bringing communities together from across the state to learn about policies and to support a healthy and equitable California.

ENACT Day April 30,2021

ENACT Day

April 30, 2021 | 10am – 2pm PT

ENACT Day is an annual advocacy event bringing communities together from across the state to learn about policies and to support a healthy and equitable California. This opportunity provides policymakers with information to make more informed decisions by using our voices to shape policies for better outcomes.

Focus areas include community safety, housing access, economic and environmental justice, public health infrastructure, and more.

Register Here

 

Virtual ENACT Day will be split into two parts:

ENACT Day | 10am – 11:30am PT
During this Virtual Town Hall portion of the event, attendees will learn about ENACT Day, hear from speakers, stakeholders, and other advocates about pressing health equity issues and more!

Legislative visits | 12:00pm – 2pm PT
Break into smaller groups by region, prepare your agenda, and then meet a California state representative. Visits will take place between 12pm-2pm, and you’ll have the opportunity to sign up for the slots that best fit your schedule.

 

In Partnership with: 

ENACT Day sponsors


More Updates

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Close

Breakthrough Infection Study of Over 600,000 Veterans Shows Declining COVID-19 Vaccine Protection

A new pre-print study of over 600,000 veterans by researchers from PHI and the Veterans Affairs Medical Center finds that overall COVID-19 vaccine protection declined significantly between February and August 2021. Declines were greatest for the Johnson & Johnson vaccine (from 88% in March to 3% in August), followed by PfizerBioNTech (91% to 50%) and Moderna (92% to 64%).

More

Continue to PHI.org